Bernstein Reinstates Regeneron Pharma (REGN) at Market Perform
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $695.42 +0.03%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 15 | New: 11
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 15 | New: 11
Join SI Premium – FREE
Bernstein reinstates coverage on Regeneron Pharma (NASDAQ: REGN) with a Market Perform rating and a price target of $309.00.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $300.77 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts Kymera Therapeutics (KYMR) at Hold
- Goldman Sachs Reinstates Steel Dynamics (STLD) at Buy
- Morgan Stanley Resumes Kinetik Holdings, Inc. (KNTK) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Sanford C. BernsteinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
